Probleme bei der Darstellung von ARIVA.DE?

  • Laden unsere Charts bei Ihnen nicht?
  • Wird unser Forum bei Ihnen nicht korrekt dargestellt?

Sie nutzen einen Adblocker, der hierfür verantwortlich ist. Hierauf hat ARIVA.DE leider keinen Einfluss. Bitte heben Sie die Blockierung von ARIVA.DE in Ihrem Adblocker auf.

Probleme bei der Darstellung von ARIVA.DE?


22:23 Uhr
ROUNDUP/Aktien New York Schluss: Wieder Rekordkurse - außer für den Nasdaq 100

Heska Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016

Mittwoch, 19.10.2016 14:05 von

PR Newswire

LOVELAND, Colo., Oct. 19, 2016 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostics and products, plans to announce its third quarter 2016 financial results in a press release to be issued on Tuesday, November 1, 2016 before the market opens. The Company plans to host a conference call to discuss the results at 9 a.m. MT / 11 a.m. ET on the same day, Tuesday, November 1, 2016.

To access the conference call:

  • From within the United States, please dial 1-888-599-8667
  • From outside of the United States, please dial 1-913-312-1502
  • Reference Conference ID: 9382912

The conference call will be webcast live from the Company's website on

A telephonic replay of the conference call will be available beginning two hours after the end of the call and continue through 11:59 p.m. ET on Tuesday, November 8, 2016.

To access the replay:

  • From within the United States, please dial 1-844-512-2921
  • From outside the United States, please dial 1-412-317-6671
  • Reference Replay Pin Number: 9382912

The webcast will also be archived on until December 31, 2016.

About Heska

Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostics and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software, and single use offerings such as in-clinic heartworm diagnostic tests, heartworm preventives, allergy immunotherapy and allergy testing. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space.  For further information on Heska and its products, visit the company's website at

At Heska Corporation:

At Hayden IR:

John McMahon, Chief Financial Officer          

Brett Maas, Managing Partner




To view the original version on PR Newswire, visit:

SOURCE Heska Corporation